-
News
Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides – NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs
SHELTON, CONNECTICUT - July 6, 2023 - NanoViricides, Inc. (NYSE American: NNVC) reports that the clinical trial of its broad-spectrum…
Read More » -
New telehealth certification available to health care professionals
[ad_1] (NewMediaWire) – July 05, 2023 – DALLAS — The COVID-19 pandemic radically changed the way health care professionals serve…
Read More » -
US Nuclear Corp. Announces First Quarter 2023 Results
[ad_1] LOS ANGELES, CA – (NewMediaWire) – July 05, 2023 – US Nuclear Corp. (OTC-QB: UCLE), a leading manufacturer of…
Read More » -
LiveOne Surges with Record 75K New Members in June
[ad_1] Quarterly Members Expanded by 194K, a 59% Increase from Prior Year 6 Month Members Shot up by 371K, a…
Read More » -
CGrowth Capital Inc. Discovers Significant High-Grade Lithium Deposits
[ad_1] NEW YORK, NY – (NewMediaWire) – July 5, 2023 – CGrowth Capital Inc. (OTC: CGRA) is pleased to announce…
Read More »
Trending Tickers
WISH
$9.18
27.72%
WISH
$9.18
27.72%
WISH
$9.18
27.72%
Follow us on Twitter